Literature DB >> 29202939

Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis.

Kosuke Kawai1, Barbara P Yawn2.   

Abstract

OBJECTIVE: To systematically review studies examining risk factors for herpes zoster (HZ).
METHODS: We performed a literature search using PubMed, EMBASE, and Web of Science for articles published from January 1, 2003, to February 1, 2017. A random-effects model was used to summarize the risk ratio (RR) or odds ratio (OR) and 95% CI.
RESULTS: Of the 3450 studies screened, we included 84 studies in the systematic review and conducted meta-analysis in 62 studies. Women were at increased risk of HZ compared with men (pooled adjusted RR, 1.31; 95% CI, 1.27-1.34). Black individuals had almost half the risk of HZ as white individuals (pooled RR, 0.54; 95% CI, 0.47-0.63). Family history was found to be a risk factor for HZ (pooled OR, 3.59; 95% CI, 2.39-5.40). Autoimmune diseases, including rheumatoid arthritis (pooled RR, 1.67; 95% CI, 1.41-1.98) and systemic lupus erythematosus (pooled RR, 2.10; 95% CI, 1.40-3.15), were associated with an elevated risk of HZ. Other comorbidities were associated with an increased risk of HZ, with the pooled RRs ranging from 1.25 (95% CI, 1.13-1.39) for asthma to 1.30 (95% CI, 1.17-1.45) for diabetes mellitus and 1.31 (95% CI, 1.22-1.41) for chronic obstructive pulmonary disease.
CONCLUSION: Our review revealed that female sex, race/ethnicity, family history, and comorbidities are risk factors for HZ. Efforts are needed to increase the uptake of zoster vaccination.
Copyright © 2017 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29202939     DOI: 10.1016/j.mayocp.2017.10.009

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  53 in total

1.  Infections in the older population: what do we know?

Authors:  Didier Schoevaerdts; François-Xavier Sibille; Gaetan Gavazzi
Journal:  Aging Clin Exp Res       Date:  2019-10-26       Impact factor: 3.636

2.  Acute zoster plasma contains elevated amyloid, correlating with Aβ42 and amylin levels, and is amyloidogenic.

Authors:  Andrew N Bubak; Cheryl Beseler; Christina N Como; Stephen K Tyring; Christopher Haley; Teresa Mescher; James E Hassell; Randall J Cohrs; Huntington Potter; Maria A Nagel
Journal:  J Neurovirol       Date:  2020-05-08       Impact factor: 2.643

3.  Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States.

Authors:  Ryan R Thompson; Christina L Kong; Travis C Porco; Eric Kim; Caleb D Ebert; Nisha R Acharya
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

4.  Ultraviolet Radiation Exposure and the Risk of Herpes Zoster in Three Prospective Cohort Studies.

Authors:  Kosuke Kawai; Trang VoPham; Aaron Drucker; Sharon G Curhan; Gary C Curhan
Journal:  Mayo Clin Proc       Date:  2019-12-26       Impact factor: 7.616

5.  Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review.

Authors:  Susannah L McKay; Angela Guo; Steven A Pergam; Kathleen Dooling
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

6.  Varicella-Zoster Virus Infection of Primary Human Spinal Astrocytes Produces Intracellular Amylin, Amyloid-β, and an Amyloidogenic Extracellular Environment.

Authors:  Andrew N Bubak; Christina N Como; Christina M Coughlan; Noah R Johnson; James E Hassell; Teresa Mescher; Christy S Niemeyer; Ravi Mahalingam; Randall J Cohrs; Timothy D Boyd; Huntington Potter; Holger A Russ; Maria A Nagel
Journal:  J Infect Dis       Date:  2020-03-16       Impact factor: 5.226

7.  Risk of herpes zoster in psoriasis patients receiving systemic therapies: a nationwide population-based cohort study.

Authors:  Sze-Wen Ting; Sze-Ya Ting; Yu-Sheng Lin; Ming-Shyan Lin; George Kuo
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

8.  The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials.

Authors:  Joon Hyung Kim; John Diaz-Decaro; Ning Jiang; Shinn-Jang Hwang; Eun Ju Choo; Maribel Co; Andrew Hastie; David Shu Cheong Hui; Junya Irimajiri; Jacob Lee; Edward Man-Fuk Leung; Haiwen Tang; Tomomi Tsuru; Philip Watson; Zhenhua Wu; Chong-Jen Yu; Yanfei Yuan; Toufik Zahaf; Anthony L Cunningham; Anne Schuind
Journal:  Hum Vaccin Immunother       Date:  2021-02-19       Impact factor: 3.452

9.  Amylin, Aβ42, and Amyloid in Varicella Zoster Virus Vasculopathy Cerebrospinal Fluid and Infected Vascular Cells.

Authors:  Andrew N Bubak; Cheryl Beseler; Christina N Como; Christina M Coughlan; Noah R Johnson; James E Hassell; Anna M Burnet; Teresa Mescher; D Scott Schmid; Colin Coleman; Ravi Mahalingam; Randall J Cohrs; Timothy D Boyd; Huntington Potter; Ali H Shilleh; Holger A Russ; Maria A Nagel
Journal:  J Infect Dis       Date:  2021-04-08       Impact factor: 5.226

Review 10.  Incidence of Herpes Zoster in HIV-Infected Patients Undergoing Antiretroviral Therapy: A Systematic Review and Meta-analysis.

Authors:  Han-Chang Ku; Yi-Tseng Tsai; Sriyani-Padmalatha Konara-Mudiyanselage; Yi-Lin Wu; Tsung Yu; Nai-Ying Ko
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.